Marc d'Abbadie

Direktor/Vorstandsmitglied bei

Spark Nw Carry Partner LLP

Health Technology

Health Services

Consumer Services

Profil

Dr. Marc d'Abbadie is an Investment Director at SPARK Impact Ltd. He is on the Board of Directors at Dadu Investments Ltd., Nwf4b Directors Ltd., Spark Nw Carry Partner LLP and Videregen Ltd. Dr. d'Abbadie was previously employed as a Non-Executive Director by Evgen Pharma Plc, a Non-Executive Director by Evgen Ltd., a Non-Executive Director by Absynth Biologics Ltd., a Non-Executive Director by EnXray Ltd., a Consultant by McKinsey & Co., Inc., and a Non-Executive Director by Zilico Ltd. He received his graduate degree from Trinity College, Cambridge and a doctorate degree from the University of Cambridge.

Aktive Positionen von Marc d'Abbadie

Unternehmen	Position	Beginn
SPARK Impact Ltd. SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements.	Private Equity Investor	-
Videregen Ltd. Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation	Direktor/Vorstandsmitglied	-
Spark Nw Carry Partner LLP	Direktor/Vorstandsmitglied	-
Nwf4b Directors Ltd.	Direktor/Vorstandsmitglied	-
Dadu Investments Ltd.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Marc d'Abbadie

Ehemalige bekannte Positionen von Marc d'Abbadie

Unternehmen	Position	Ende
THERACRYF PLC	Direktor/Vorstandsmitglied	08.11.2018
EnXray Ltd. EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies	Direktor/Vorstandsmitglied	-
Absynth Biologics Ltd. Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies	Direktor/Vorstandsmitglied	-
Zilico Ltd. Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix	Direktor/Vorstandsmitglied	-
░░░░░░░░ ░░░░░ ░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

Sehen Sie sich die Erfahrung von Marc d'Abbadie im Detail an

Ausbildung von Marc d'Abbadie

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Marc d'Abbadie im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Evgen Pharma Plc Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease	Health Services
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trinity College, Cambridge Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Absynth Biologics Ltd. Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies	Health Technology
Zilico Ltd. Zilico Ltd. BiotechnologyHealth Technology Develops a medical device to detect cervical cancer and pre-cancerous cells in the cervix	Health Technology
Evgen Ltd. Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease	Health Services
SPARK Impact Ltd. SPARK Impact Ltd. Investment ManagersFinance SPARK Impact invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, diagnostics, clinical research, analytical services & sciences, healthcare technologies and medical devices. It provides financing for early and growth stage capital requirements.	Finance
Videregen Ltd. Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation	Health Technology
Spark Nw Carry Partner LLP
Nwf4b Directors Ltd.
Dadu Investments Ltd.
EnXray Ltd. EnXray Ltd. Information Technology ServicesTechnology Services Develops sterilization technology solutions for medical device manufacturing companies	Technology Services